Fight for Sight is a nonprofit organization in the United States which funds medical research in vision and ophthalmology. It was formed in 1946 as the National Council to Combat Blindness (NCCB),[1][2] the first non-profit organization in the United States to fund vision research; 2011 marked its 65th anniversary.
Based in New York City, Fight for Sight provides funding and acknowledgment to promising scientists early in their eye research careers, before they are eligible for government support from the National Institutes of Health. Grants are made in three main categories: Post-Doctoral Fellowships to those with a Ph.D., M.D., O.D., Dr.PH, or D.V.M.; Grants-in-Aid to junior professors at research universities, and Summer Student Fellowships to medical students, graduate students, and undergraduate students.
Led by its Scientific Review Committee selection process, the organization provides funding for eye and vision diseases and conditions. Fight for Sight has provided support directly or indirectly to major advances in ophthalmology and vision research, including donor cornea preservation, ophthalmic lasers, glaucoma therapies, genetic research, and the Intraocular Lens (IOL).
Early on, Fight for Sight helped create national awareness and funds for vision research outside of its own fundraising when organization founder Mildred Weisenfeld coordinated testimony on eye research to Congress in 1949, leading to the creation of the National Institute of Neurological Disease and Blindness, and in December 1968 the establishment of the National Eye Institute (NEI) in the National Institutes of Health (NIH).[1]
Although a modest foundation not exceeding $5 million in annual endowment, Fight for Sight had given out more than $20 million in grants to over 3,000 eye researchers by 2009. Fight for Sight celebrated its 65th anniversary in 2011.
Organizational partnerships with Fight for Sight include The Eye-Bank for Sight Restoration, Streilein Foundation for Ocular Immunology, the North American Neuro-Ophthalmology Society, and WomensEyeHealth.org.
Fight for Sight in the U.S. is unaffiliated with the younger organizations with the same name in the UK or in Ireland.
Notable alumni
Numerous leaders in eye and vision research and academia received a Fight for Sight grant early in their careers, including Harold Scheie, MD (1950), who founded the Scheie Eye Institute at the University of Pennsylvania, Arthur Jampolsky, MD (1952), whose efforts led to the creation of the Smith-Kettlewell Eye Research Institute, A. Edward Maumenee, MD (1958) director of the Wilmer Eye Institute, founder of the Eye Bank Association of America and potent force behind the creation of the NEI at the National Institutes of Health, Carl Kupfer, MD (1961), Director of the NEI for 30 years, László Bitó, PhD (1965), who developed the glaucoma drug Xalatan, Robert Machemer, MD (1966) the "father" of modern retinal surgery, Irene H. Maumenee, MD (1973) internationally renowned pediatric ophthalmologist and expert in hereditary eye diseases, David Abramson, MD (1979), renowned for his expertise in treating childhood eye tumors, Paul Sieving, MD, PhD (1980), current Director of the NEI and Jayakrishna Ambati, MD (2002), winner of the ARVO Cogan Award, given for significant scientific accomplishments to a scientist under 40 years old.
Leaders
The organization's identity has been closely aligned with its founder Mildred Weisenfeld, who lost her vision to retinitis pigmentosa two years before starting the nonprofit. Weisenfeld lead the organization as Executive Director for 50 years, from 1946 to 1996. Among other notable leaders at Fight for Sight were board president Herbert Tenzer, who had been a member of the United States House of Representatives, and comedian Bob Hope who was an honorary chairman from 1960. Other honorary board members included Milton Berle, Ed Sullivan and Sammy Davis Jr.
Weisenfeld was honored many times for her lifelong work in bringing awareness and funding to eye research. On Fight for Sight's 25th anniversary in 1971, she was recognized by congratulatory letters from President Richard Nixon and Fight for Sight supporter New York City Mayor John Lindsay.
The industry group ARVO (Association of Research in Vision and Ophthalmology) honored Fight for Sight's founder by establishing the Weisenfeld Award for Excellence in Ophthalmology in 1986,[3] to annually recognize individuals for scholarly contributions to clinical ophthalmology.
Long term leaders of the board included Hon. Richard Lane and Kenneth Barasch, M.D.
History
First Lady Eleanor Roosevelt wrote about the NCCB in its first year of existence, drawing attention to the goal of raising $50,000 for eye clinics and treat retinitis pigmentosa (RP).[4] Experimental treatments funded by NCCB began the first year at New York Hospital and the N.Y. Medical College of Flower-Fifth Avenue on a few hundred people with RP.
Founder Mildred Weisenfeld, along with blind Attorney General William E. Powers, presented a Norman Rockwell painting to President Harry Truman on September 19, 1950, to honor his signing of legislation aiding the blind. In the same year, Weisenfeld and wealthy New York entrepreneur Mary Lasker encouraged adding the word "blindness" to the founding title of The National Institute of Neurological Disorders and Blindness (NINDB), now the National Institute of Neurological Disorders and Stroke.
Summer Student Fellowships[5] and Post-Doctoral awards were added by the organization in 1955 to encourage young investigators into ophthalmic research, providing a sort of funding "ladder" leading up to Grants-In-Aid.
The name Fight for Sight was officially adopted by the organization in late 1959, and gradually replaced use of the original name National Council to Combat Blindness.
In 1983-84, Fight for Sight had a one-year moratorium on new awards to assess its giving strategy. For a period from 1983 to 1988, the Fight for Sight Awards Program was then administered in association with ARVO, assisted by Arthur M. Silverstein, PhD, of Johns Hopkins. Then in 1988-2002, Fight for Sight affiliated with National Society to Prevent Blindness (which became Prevent Blindness America after 1992) as a "research division," during which ARVO still assisted with the selection of grant recipients. NSPB/PBA contributed funding. In 2003, Fight for Sight returned to selecting grant recipients though its own independent Scientific Review Committee.
Leagues
In 1949, Fight for Sight started a "women's division" which later turned into a few dozen local women's auxiliary leagues in New York, New Jersey, Pennsylvania, and Florida. During their height in the 1980s, they contributed up to $330,000 annually. New York state included one in Manhattan; several in Brooklyn: Park Circle, Bensonhurst, Flatbush, Sheepshead, Shorefront; in Queens: North Shore, Rockaways, Seaside; and others in the Bronx, Westchester, and Long Island (Nassau), there was one for Northern NJ, several in Pennsylvania (Philadelphia: Greater, Main Line, Mount Airy, Cheltenham, and Northeast) and five in Florida (South Palm Beach, Hollywood, Delray Beach, Deerfield Beach, Greater Miami).
"Lights On" fundraiser, celebrity supporters
The annual Fight for Sight fundraiser, the "Lights On" variety show, was the organization's signature event and was a who's-who of top singers, comedians, actors and politicians from 1949 into the mid-1990s.
Fight for Sight also supported general eye clinics, such as the Harkness Eye Institute at Columbia University, the Philadelphia Geriatric Clinic, and New York–Presbyterian Hospital.
Overseas in the 1960s, Fight for Sight also supported a Mobile Eye Clinic in Jerusalem, Israel, for treatment and eradication of trachoma, and an eye bank at Mahatma Gandhi Memorial College, a corneal research project in Indore, India, and research in Japan, Korea, Turkey, Hungary, Italy, Switzerland, Sweden, Belgium, The Netherlands, England, Argentina, Mexico, and Uganda.
Related Research Articles
The National Eye Institute (NEI) was established in 1968 and is located in Bethesda, Maryland. The NEI is one of 27 institutes and centers of the US National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The mission of NEI is to prolong and protect the vision of the American people. The NEI conducts and performs research into treating and preventing diseases affecting the eye or vision.
The Lions Eye Institute (LEI) is an Australian medical research institute affiliated with the University of Western Australia. It was established in 1983 with support of the Lions Clubs of Western Australia and headquartered in the Perth suburb of Nedlands, Western Australia. The LEI is a not-for-profit centre of excellence that combines an ophthalmic clinic with scientific discovery developing techniques for the prevention of blindness and the reduction of pain from blinding eye conditions.
Penn Presbyterian Medical Center ("Presby") is a hospital located in the University City section of West Philadelphia. It was founded by Reverend Ephraim D. Saunders in 1871 and formally joined the University of Pennsylvania Health System in 1995. Penn Presbyterian is spread out on a campus bounded by Market Street, Powelton Avenue, 38th Street, and Sloan Street.
Patricia Era Bath was an American ophthalmologist, inventor, humanitarian, and academic. She invented an improved device for laser cataract surgery. Her invention was called Laserphaco Probe, which she patented in 1986. She also became the first woman member of the Jules Stein Eye Institute, first woman to lead a post-graduate training program in ophthalmology, and first woman elected to the honorary staff of the UCLA Medical Center. Bath was the first African-American person to serve as a resident in ophthalmology at New York University. She was also the first African-American woman to serve on staff as a surgeon at the UCLA Medical Center. Bath was the first African-American woman doctor to receive a patent for a medical purpose. A holder of five patents, she also founded the non-profit American Institute for the Prevention of Blindness in Washington, D.C.
AMD Alliance International is a non-profit coalition of the world’s leading vision, seniors and research organizations working to raise awareness of age-related macular degeneration, understanding of available options for prevention, early detection, treatment, rehabilitation and support services. It is the only international organization in the world that concentrates exclusively on age related macular degeneration, the leading cause of vision loss in the developed world.
The Illinois Eye & Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice. Currently, the National Institutes of Health (NIH) ranks the department 4th nationally in ophthalmology research funding and 1st in the Midwestern United States and Chicago metropolitan area.
Fight for Sight is a UK charity funding research into the prevention and treatment of blindness and eye disease.
The John A. Moran Eye Center at the University of Utah serves as the largest ophthalmology clinical care and research facility in the Mountain West with more than 60 faculty members and 10 satellite clinics.
Mildred Mosler Weisenfeld is the Brooklyn-born founder of national not-for-profit foundation the National Council to Combat Blindness in 1946, now known as Fight for Sight, an organization based in New York City that provides initial funds to promising scientists early in their careers. For 50 years, Weisenfeld was a one-woman campaign to increase funding for eye research, despite losing her own vision and having no scientific training.
David Glendenning Cogan was an American ophthalmologist.
Dr. George Spaeth is an American ophthalmologist specializing in glaucoma at Wills Eye Institute. Spaeth is also affiliated with Thomas Jefferson University Hospital, Graduate Hospital of the University of Pennsylvania, Chestnut Hill Hospital, Bryn Mawr Hospital, and Miner's Memorial Hospital.
José-Alain Sahel is a French ophthalmologist and scientist. He is currently the chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, director of the UPMC Eye Center, and the Eye and Ear Foundation Chair of Ophthalmology. Dr. Sahel previously led the Vision Institute in Paris, a research center associated with the one of the oldest eye hospitals of Europe - Quinze-Vingts National Eye Hospital in Paris, founded in 1260. He is a pioneer in the field of artificial retina and eye regenerative therapies. He is a member of the French Academy of Sciences.
Stephen H. Tsang is an American ophthalmologist and geneticist. He is currently a Professor of Ophthalmology, and Pathology and Cell Biology at Columbia University Irving Medical Center in New York. He has been married to Jing Peng in 2020.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Emily Ying Chew, M.D., is an American ophthalmologist and an expert on the human retina with a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She currently works for the National Eye Institute (NEI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she serves as deputy director of the Division of Epidemiology and Clinical Applications (DECA) and the Institute's deputy clinical director. She designs and implements Phase 1, 2 and 3 clinical trials at the NIH Clinical Center. Chew is board certified in ophthalmology.
Doheny Eye Institute established in 1947, is a nonprofit ophthalmic research institute. The doctors and scientists of Doheny Eye Institute undertake basic and clinical research, a role known as a physician-scientist.
Alfred Edward Maumenee, Jr. was an American ophthalmologist who pioneered treatments for retinal diseases, macular degeneration and glaucoma and was a leading surgeon for corneal transplants and cataracts.
C. Stephen Foster is an American ophthalmologist, known for his research and treatment of ocular inflammatory disease (OID) with immunomodulatory therapy. He has published over 700 peer reviewed journal articles and authored 3 textbooks in his field.
Daniel M. Albert is an American ophthalmologist, ocular cancer researcher, medical historian, and collector of rare books and ocular equipment. As of 2018, he is Professor of Ophthalmology at the Casey Eye Institute, Oregon Health & Science University.
Hatice Nida Sen is an ophthalmologist researching mechanisms involved in different forms of human uveitis. She is a clinical investigator at the National Eye Institute.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
